SEC Filing Summary: Reviv3 Procare Company (8-K)
Business Context and Reporting Period
This Form 8-K was filed by Reviv3 Procare Company on August 25, 2022. The report serves to announce the Company's financial results for the fiscal year ended May 31, 2022. The filing incorporates by reference a press release (Exhibit 99.1) containing the detailed results.
Key Financial Metrics
The filing text itself does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These figures are contained within the referenced press release (Exhibit 99.1), which is not included in the provided text.
Material Changes
No specific material changes versus the prior comparable period are detailed in the body of this 8-K. The document solely references the issuance of the annual results press release.
Guidance, Outlook, and Risks
The filing does not contain management commentary, forward-looking guidance, specific risk factors, or details on contingencies. It notes that the information in the press release is furnished and not deemed "filed" for purposes of Section 18 of the Exchange Act, limiting liability under that section.
Investor Verification Checklist
- Verify the specific revenue and net income figures in the attached Exhibit 99.1 (Earnings Press Release).
- Confirm the Company's current liquidity position and debt obligations as detailed in the full financial statements.
- Review the press release for any forward-looking statements or guidance for the upcoming fiscal year.
- Note that the registrant is not an emerging growth company and has no securities registered under Section 12(b) of the Act.